Answers are grounded in this paper and cite their sources.
Retrospective case-control study shows increased odds of sialolithiasis linked to specific medications in older adults, indicating a risk factor.
BACKGROUND: Sialolithiasis pathophysiology is multifactorial, with systemic medications often hypothesised as a key contributor, particularly in older adults (Drug-Induced Sialolithiasis). However, robust evidence supporting this theory is limited. This study aimed to investigate the association between common medication classes and sialolithiasis in an older Israeli cohort. METHODS: A nationwide retrospective case-control study (2005-2024) was conducted using the Clalit Health Services database. Sialolithiasis cases were matched 1:3 with controls based on age and gender. After stratification using a Gaussian Mixture Model (age > 50.28 years), logistic regression analyses assessed the association between sialolithiasis and antihyperlipidemic, antihypertensive, psychiatric, neurologic and antidiabetic medications. Significance was considered under p-value of 0.05. RESULTS: The cohort included 32,088 individuals (8015 cases). Multivariable analysis revealed significantly increased odds of sialolithiasis associated with neurologic (OR 1.31, p < 0.001), antihyperlipidemic (OR 1.18, p < 0.001), psychiatric (OR 1.16, p < 0.001) and antihypertensive medications (OR 1.08, p = 0.016). Antidiabetics showed no significant association. CONCLUSIONS: This large-scale analysis strongly supports the theory of Drug-Induced Sialolithiasis. The independent association between these four common medication classes and increased odds of sialolithiasis in older adults suggests that medication-induced hyposalivation is a major, quantifiable risk factor in the aetiology of the condition.
No takes yet. Share an insight, caveat, or question.
Avishai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: